Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL201849 | 0.75 | ALDH1A1 (0.51) | ALDH1A1KMT2ATSHRKDM4ELMNA | |
| SCHEMBL21895375 | 0.73 | KDM4E (0.53) | ALDH1A1KMT2AGAAKDM4ELMNA | |
| SCHEMBL3197540 | 0.70 | KDM4E (0.45) | ALDH1A1KMT2ACYP1A2CYP2C9PKM | |
| Toluene SCHEMBL27618261 | 0.70 | KDM4E (0.46) | ALDH1A1KMT2APKMTSHRKDM4E | |
| SCHEMBL31540359 | 0.69 | CYP1A2 (0.75) | KMT2ACYP1A2GAACYP2C9PKM | |
| SCHEMBL11582365 | 0.69 | ALDH1A1 (0.52) | ALDH1A1KMT2APKMTSHRKDM4E | |
| SCHEMBL14449130 | 0.69 | KDM4E (0.49) | ALDH1A1KMT2AKDM4ELMNARAB9A | |
| SCHEMBL818204 | 0.69 | KDM4E (0.49) | ALDH1A1KMT2AKDM4ELMNARAB9A | |
| SCHEMBL32688583 | 0.69 | ALDH1A1 (0.59) | ALDH1A1KMT2AGAATSHRKDM4E | |
| SCHEMBL7715902 | 0.69 | KDM4E (0.52) | ALDH1A1KMT2AGAAKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7675587-B2 | Polarizing plate and process for producing the same | JSR CORPORATION (JP) | 2010-03-09 | — | — | US | disclosed |
| US-20090176950-A1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | JSR CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1983023-A1 | Radiation-curable composition, composite and manufacturing method thereof | JSR Corporation (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1626294-A2 | Polarizing plate and process for producing the same | JSR Corporation (JP) | 2006-02-15 | — | — | EP | disclosed |
| US-20060027322-A1 | Polarizing plate and process for producing the same | JSR CORPORATION (JP) | 2006-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176950-A1 | METAL HYDRIDE COMPLEX, METHOD OF HYDROGENATING RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN, AND PROCESS FOR PRODUCING PRODUCT OF HYDROGENATION OF RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | HPD, HMOX2, HAO2 | ALDH1A1 2201/4885KMT2A 3197/4885CYP1A2 328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.